drugset / Trial / NCT01448772
Comparative Bioavailability of Dronabinol Oral Solution Versus Branded Capsule 5 mg Under Fasting Conditions
RandomizedCrossoverOpen-label
Summary
This is a comparative study to assess bioavailability of a proposed alternate dosage form against the current FDA-approved branded product.
Timeline
- Start
- 2011-10
- Primary completion
- 2011-12
- Completion
- 2011-12
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Dronabinol | Other / unclassified | 5 mg | Oral |
Indications
No indication recorded.